Novo partners with Orbis, deepening investment in oral peptide drugs
Published . Updated .
The potentially $1.4 billion alliance will see the two companies collaborate on “macrocycles” that could yield oral treatments for cardiometabolic diseases.
Directly affected
- No company is named in this report.
Indirectly affected
- EUIG iShares Euro Investment Grade Corporate Bond USD Hedged ETF
GA selected EUIG as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- FPRO FIDELITY REAL ESTATE INVESTMENT ETF
GA selected FPRO as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- FSEC FIDELITY INVESTMENT GRADE SECURITIZED ETF
GA selected FSEC as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GIGB GOLDMAN SACHS ACCESS INVESTMENT GRADE CORPORATE BOND ETF
GA selected GIGB as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The potentially $1.4 billion alliance will see the two companies collaborate on “macrocycles” that could yield oral treatments for cardiometabolic diseases.
Source: BioPharma Dive
iShares Euro Investment Grade Corporate Bond USD Hedged ETF (EUIG) since this story, compared with the market
Who gains and who loses around iShares Euro Investment Grade Corporate Bond USD Hedged ETF (EUIG)
Companies tied to this story
- EUIG iShares Euro Investment Grade Corporate Bond USD Hedged ETF
iShares Euro Investment Grade Corporate Bond USD Hedged ETF (EUIG) is linked, with no stored direction, medium confidence in the 17 Sep 2026 story “Novo partners with Orbis, deepening investment in oral peptide drugs.” Reason on file: GA selected EUIG as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- FPRO Fidelity Real Estate Investment Etf
For “Novo partners with Orbis, deepening investment in oral peptide drugs,” Fidelity Real Estate Investment Etf (FPRO) is linked, with no stored direction, medium confidence. Reason on file: GA selected FPRO as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- FSEC Fidelity Investment Grade Securitized Etf
In “Novo partners with Orbis, deepening investment in oral peptide drugs,” Fidelity Investment Grade Securitized Etf (FSEC) is linked, with no stored direction, medium confidence. Reason on file: GA selected FSEC as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GIGB Goldman Sachs Access Investment Grade Corporate Bond Etf
Goldman Sachs Access Investment Grade Corporate Bond Etf (GIGB) is linked, with no stored direction, medium confidence in the 17 Sep 2026 story “Novo partners with Orbis, deepening investment in oral peptide drugs.” Reason on file: GA selected GIGB as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
iShares Euro Investment Grade Corporate Bond USD Hedged ETF (EUIG)
iShares Euro Investment Grade Corporate Bond USD Hedged ETF (EUIG) is the company in “Novo partners with Orbis, deepening investment in oral peptide drugs,” the 17 Sep 2026 this story story.
The link for iShares Euro Investment Grade Corporate Bond USD Hedged ETF (EUIG) is this: GA selected EUIG as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Fidelity Real Estate Investment Etf (FPRO) is here too. Its reason reads: GA selected FPRO as a RELATED security because its canonical security name directly matches this event's themes: investment. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for iShares Euro Investment Grade Corporate Bond USD Hedged ETF (EUIG)
EUIG traded between 48.96 and 48.96 across 1 sessions. The latest close on file is 48.96. FPRO traded between 23.20 and 24.38 across 8 sessions. The latest close on file is 23.37. FSEC traded between 41.41 and 42.79 across 20 sessions. The latest close on file is 42.10.
A simple score for iShares Euro Investment Grade Corporate Bond USD Hedged ETF (EUIG)
33 out of 100
“Novo partners with Orbis, deepening investment in oral peptide drugs” scores 33 out of 100. The score uses 1 sources, and 4 linked companies.